FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns a chemicopharmaceutical industry, and also to medicine and veterinary science and represents a pharmaceutical injection composition for treatment of the purulent-destructive processes, characterised that it contains Tilorone and a hydrophylic dissolvent, where as a hydrophylic dissolvent it contains the substances chosen from a number: the emulsion of perfluoroorganic bonds, an isotonic solution of sodium chloride or their admixture, and in addition contains Novocainum; thereat, the components in the composition are in a certain mass parity.
EFFECT: tilorone application expansion, restoration of local immunity and a biocenosis of a skin and mucosas at treatment of purulent-destructive processes of skin and mucosas, especially at a deep locating of the centres of a lesion, depression of a secondary necrosis of tissues on the amased sites, cupping of inflammatory reactions, maintenance of local anesthetic effect, healing acceleration.
3 cl, 1 ex, 2 tbl
